CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
FaceAnxiety +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02579915
NCT02579915N/ACompleted
CompareCT.gov

Phase 2 Randomized Controlled Trial of Attention and Interpretation Modification (AIM) for Anxiety Disorders in Primary Care

Brown University·interventional·Posted Oct 20, 2015·Updated Feb 7, 2020

In Brief

A clinical study evaluating FaceAnxiety and Symptom Tracking for Anxiety Disorders. Completed, enrolled 40 participants across 1 site.

Detailed Summary

The purpose of the study is to develop a personalized, user-friendly computerized treatment for anxiety disorders linked to primary care. The computerized treatment is a type of Cognitive Bias Modification, which targets attention and interpretation biases known to maintain anxiety disorders.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnxiety Disorders
CountriesUnited States
CollaboratorsMclean Hospital, Memorial Hospital of Rhode Island, National Institute of Mental Health (NIMH)

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedOct 20, 2015
Enrollment StartSep 1, 2015
Primary CompletionDec 31, 2018
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 10.7 years ago

Interventions

FaceAnxietybehavioral

Computerized treatment targeting mental habits and primary care linkage.

Symptom Trackingbehavioral

Weekly self-assessment with validated questionnaires and primary care linkage